Medicine passport

Skyrizi 180 mg oplossing voor injectie in een patroon 180 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Risankizumab
Strength
180 mg
Form
oplossing voor injectie
ATC code
L04AC18
Registered in
Netherlands · AbbVie Deutschland GmbH & Co. KG
Prescription
Prescription only
RVG
EU/1/19/1361

Source: Geneesmiddeleninformatiebank · 2026-09-30

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Spain 1 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
SKYRIZI180 mg · solución inyectable en cartuchoPrescription onlyAbbvie Deutschland Gmbh & Co. Kg1191361007

Source: CIMA — Centro de Información online de Medicamentos (Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)) · 2026-09-30 · Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-30. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/nl/en/medicines/skyrizi-180-mg-oplossing-voor-injectie-in-een-patroon-180-mg-oplossing-v